Comparison of irinotecan/platinum versus etoposide/platinum chemotherapy for extensive-stage small cell lung cancer: A meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of irinotecan/platinum versus etoposide/platinum chemotherapy for extensive-stage small cell lung cancer: A meta-analysis

Published:2017-07-13 Issue:6 Volume:26 Page:e12723
ISSN:0961-5423
Container-title:European Journal of Cancer Care
language:en
Short-container-title:Eur J Cancer Care

Author:

Han D.¹^ORCID,Wang G.¹,Sun L.¹,Ren X.¹,Shang W.¹,Xu L.¹,Li S.²

Affiliation:

1. Department of Respiratory and Critical Care Medicine; Shaanxi Provincial People's Hospital; Xi'an China

2. Department of Respiratory and Critical Care Medicine; The First Affiliated Hospital of Medical College; Xi'an Jiaotong University; Xi'an China

Publisher

Wiley

Subject

Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ecc.12723/fullpdf

Reference18 articles.

1. Comorbidity in patients with small-cell lung cancer: Trends and prognostic impact;Aarts;Clinical Lung Cancer,2015

2. Treatment of extensive small cell lung cancer;Davies;Hematology/Oncology Clinics of North America,2004

3. Incorporating variations in the quality of individual randomized trials into meta-analysis;Detsky;Journal of Clinical Epidemiology,1992

4. History of small-cell lung cancer;Haddadin;Clinical Lung Cancer,2011

5. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer;Hanna;Journal of Clinical Oncology,2006

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Irinotecan/carboplatin versus Etoposide/carboplatin for extended disease small cell lung cancer (ED-SCLC): A systematic review and meta-analysis of randomized controlled trials;2024-03-07

2. Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline;Journal of Clinical Oncology;2023-12-10

3. Dissecting the genetic variations associated with response to first-line chemotherapy in patients with small cell lung cancer: a retrospective cohort study;Journal of Thoracic Disease;2023-12

4. Phase II study of IRInotecan treatment after COmbined chemo‐immunotherapy for extensive‐stage small cell lung cancer: Protocol of IRICO study;Thoracic Cancer;2023-09-07

5. Extensive-Stage Small-Cell Lung Cancer: Current Landscape and Future Prospects;OncoTargets and Therapy;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3